100% target hit on $21621) Cup and handle
2) Ascending triangle
3) Price broke neckline
Entry on 12 Aug 2022
Currently sitting on almost 100% gain.
−1.50HKD
−397.09 MHKD
391.27 MHKD
156.58 M
About KEYMED BIOSCIENCES INC
Sector
CEO
Bo Chen
Headquarters
Chengdu
Website
Employees (FY)
897
Founded
2018
ISIN
KYG5252B1023
FIGI
BBG011LTF0L9
Keymed Biosciences, Inc. is an investment holding company, which engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas. It operates through Hong Kong and China geographical segment. The company was founded on April 23, 2018 and is headquartered in Chengdu, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2162 is 34.95 HKD — it has increased by 3.86% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange KEYMED BIOSCIENCES INC stocks are traded under the ticker 2162.
KEYMED BIOSCIENCES INC is going to release the next earnings report on Aug 27, 2024. Keep track of upcoming events with our Earnings Calendar.
2162 stock is 6.33% volatile and has beta coefficient of 2.11. Check out the list of the most volatile stocks — is KEYMED BIOSCIENCES INC there?
Yes, you can track KEYMED BIOSCIENCES INC financials in yearly and quarterly reports right on TradingView.
2162 stock has risen by 13.66% compared to the previous week, the month change is a 5.75% rise, over the last year KEYMED BIOSCIENCES INC has showed a 43.26% decrease.
2162 net income for the last quarter is −438.97 M HKD, while the quarter before that showed 53.12 M HKD of net income which accounts for −926.41% change. Track more KEYMED BIOSCIENCES INC financial stats to get the full picture.
Today KEYMED BIOSCIENCES INC has the market capitalization of 9.39 B, it has decreased by 3.32% over the last week.
No, 2162 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2162 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KEYMED BIOSCIENCES INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 897.00 employees. See our rating of the largest employees — is KEYMED BIOSCIENCES INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KEYMED BIOSCIENCES INC technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KEYMED BIOSCIENCES INC stock shows the sell signal. See more of KEYMED BIOSCIENCES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on KEYMED BIOSCIENCES INC future price: according to them, 2162 price has a max estimate of 68.47 HKD and a min estimate of 52.81 HKD. Read a more detailed KEYMED BIOSCIENCES INC forecast: see what analysts think of KEYMED BIOSCIENCES INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KEYMED BIOSCIENCES INC EBITDA is −417.65 M HKD, and current EBITDA margin is −109.27%. See more stats in KEYMED BIOSCIENCES INC financial statements.